Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome

Multiple active sites and strong US enrollment continue to support Q3 2026 timing for topline data readoutClinical trial sites in Canada and the ...
VentureBeat

Meet Aardvark, OpenAI’s security agent for code analysis and patching

An aardvark works in an office typing at a desktop PC while happy human workers mill about in the background. Credit: VentureBeat made with ChatGPT Positioned as a scalable defense tool for modern ...

Aardvark Therapeutics to Present at Upcoming Investor Conferences in December

Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for ...
Nasdaq

Aardvark Therapeutics Announces Pricing of Initial Public Offering

SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule ...
The Conversation

Daytime sightings of elusive aardvarks hint at troubled times in the Kalahari

Robyn Hetem receives funding from South Africa’s National Research Foundation. Nora Marie Weyer is affiliated with the Aardvark section of the IUCN/SSC - Afrotheria Specialist Group. Aardvarks are ...